Nicox has announced results from the Whistler Phase 3b exploratory trial, evaluating the intraocular...

Bausch + Lomb has officially launched Zenlens CHROMA HOA in the United States—a custom, wavefront-gu...

Cognition Therapeutics has announced topline results from its Phase 2 Magnify study, evaluating the ...

At the 2025 ARVO Annual Meeting in Salt Lake City, a multi-stakeholder coalition announced the offic...

Isarna Therapeutics presented the final results from its Phase 2 BETTER trial on May 6 at the Associ...

EyeCool Therapeutics has announced encouraging results from a double-masked, randomized controlled p...

Perfuse Therapeutics has announced promising 24-week results from its Phase 1/2a clinical trial eval...

LumiThera has announced promising results from its LIGHTSITE 3B extension trial, highlighting contin...

Topcon Healthcare has officially launched the Institute of Digital Health (IDHea), a next-generation...

Alkeus Pharmaceuticals, Inc. presented additional 24-month results from its Phase 2 SAGA clinical tr...